Tela Bio Inc Reports Results For The Quarter Ended In December: Earnings Summary

TELA Bio

21/03/2022 21:01

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 59
cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 55 cents per share.
    * Revenue rose 47.8% to $8.37 million from a year ago; 
analysts
expected $7.98 million. 
    * TELA Bio Inc's reported EPS for the quarter was a loss
of 59
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TELA Bio Inc shares had fallen by 2.3% this quarter.
    * The company reported a quarterly loss of $8.62 million.
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$19.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 21 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated